Literature DB >> 17340062

[Magnetic resonance tomography and spectroscopy investigations of the human heart].

Bernhard Metzler1, Gert Klug.   

Abstract

The use of cardiac magnetic resonance (CMR) has emerged in the last decades. Technical innovations provide fast and high-quality imaging sequences and CMR is often proposed as a gold-standard for the in vivo evaluation of cardiac function, morphologic details and infarct size. Also the 31-phosphorous magnetic resonance spectroscopy (MRS) is a unique tool to investigate the human myocardial high-energy phosphate (HEP) metabolism in vivo. PCr/b-ATP ratio examined by MRS is mainly used as an index for cardiac energy metabolism. We have described decreased PCr/b-ATP ratios in patients with diabetes mellitus, hypercholesterolemia and hemochromatosis. The use of CMR to study the effects of ischemia time on the evolution of myocardial infarct characteristics after an acute myocardial infarction (AMI) treated with a primary angioplasty (p-PTCA) is a promising new application of this technique. Results of this study will further help to clarify the impact of ischemia time on myocardial regional functional recovery after p-PTCA.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17340062     DOI: 10.1007/s10354-007-0375-0

Source DB:  PubMed          Journal:  Wien Med Wochenschr        ISSN: 0043-5341


  9 in total

1.  Myocarditis diagnosed by magnetic resonance imaging.

Authors:  Gert Klug; Thomas Trieb; Michael F Schocke; Matthias Frick; Otmar Pachinger; Bernhard Metzler
Journal:  Wien Klin Wochenschr       Date:  2006-02       Impact factor: 1.704

2.  Correlation of cardiovascular risk scores with myocardial high-energy phosphate metabolism.

Authors:  Gert Klug; Ralf H Zwick; Agnes Mayr; Michael F Schocke; Peter Steinboeck; Werner Jaschke; Otmar Pachinger; Bernhard Metzler
Journal:  Int J Cardiol       Date:  2011-06-11       Impact factor: 4.164

3.  Evaluation of transient apical ballooning with cardiac magnetic resonance imaging and 31-phosphorous magnetic resonance spectroscopy.

Authors:  G Klug; C Wolf; T Trieb; M Frick; A Koehler; M F Schocke; W Jaschke; O Pachinger; B Metzler
Journal:  Int J Cardiol       Date:  2006-10-16       Impact factor: 4.164

4.  3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors improve myocardial high-energy phosphate metabolism in men.

Authors:  Michael F Schocke; Martin Martinek; Christian Kremser; Christian Wolf; Peter Steinboeck; Monika Lechleitner; Werner Jaschke; Otmar Pachinger; Bernhard Metzler
Journal:  J Cardiovasc Magn Reson       Date:  2003       Impact factor: 5.364

5.  Impact of exercise capacity on myocardial high-energy phosphate metabolism.

Authors:  G Klug; R H Zwick; M Frick; C Wolf; M F H Schocke; E Conci; W Jaschke; O Pachinger; B Metzler
Journal:  Int J Sports Med       Date:  2007-04-23       Impact factor: 3.118

6.  Impact of aging on cardiac high-energy phosphate metabolism determined by phosphorus-31 2-dimensional chemical shift imaging (31P 2D CSI).

Authors:  Michael F H Schocke; Bernhard Metzler; Christian Wolf; Peter Steinboeck; Christian Kremser; Otmar Pachinger; Werner Jaschke; Peter Lukas
Journal:  Magn Reson Imaging       Date:  2003-06       Impact factor: 2.546

7.  Decreased high-energy phosphate ratios in the myocardium of men with diabetes mellitus type I.

Authors:  Bernhard Metzler; Michael F H Schocke; Peter Steinboeck; Christian Wolf; Werner Judmaier; Monika Lechleitner; Peter Lukas; Otmar Pachinger
Journal:  J Cardiovasc Magn Reson       Date:  2002       Impact factor: 5.364

8.  Cardiac phosphorus-31 two-dimensional chemical shift imaging in patients with hereditary hemochromatosis.

Authors:  Michael F H Schocke; Heinz Zoller; Wolfgang Vogel; Christian Wolf; Christian Kremser; Peter Steinboeck; Gerhard Poelzl; Otmar Pachinger; Werner R Jaschke; Bernhard Metzler
Journal:  Magn Reson Imaging       Date:  2004-05       Impact factor: 2.546

9.  Detection of a silent myocardial infarction with phosphor-31 two-dimensional chemical shift imaging (31P 2-D CSI).

Authors:  Peter Steinboeck; Bernhard Metzler; Michael F H Schocke; Monika Lechleitner; Werner Jaschke; Otmar Pachinger MD
Journal:  Herz       Date:  2003-08       Impact factor: 1.443

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.